561 related articles for article (PubMed ID: 18687242)
41. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
[TBL] [Abstract][Full Text] [Related]
42. Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction.
Kandzari DE; Tcheng JE; Gersh BJ; Cox DA; Stuckey T; Turco M; Mehran R; Garcia E; Zimetbaum P; McGlaughlin MG; Lansky AJ; Costantini CO; Grines CL; Stone GW;
Am Heart J; 2006 Jun; 151(6):1288-95. PubMed ID: 16781238
[TBL] [Abstract][Full Text] [Related]
43. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
[TBL] [Abstract][Full Text] [Related]
44. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Appelbaum E; Abraham JM; Pride YB; Harrigan CJ; Peters DC; Biller LH; Manning WJ; Gibson CM
Am Heart J; 2009 Jul; 158(1):84-91. PubMed ID: 19540396
[TBL] [Abstract][Full Text] [Related]
45. Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock.
Tarantini G; Ramondo A; Napodano M; Bilato C; Isabella G; Razzolini R; Iliceto S
Am J Cardiol; 2004 May; 93(9):1081-5. PubMed ID: 15110196
[TBL] [Abstract][Full Text] [Related]
46. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
[TBL] [Abstract][Full Text] [Related]
47. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
[TBL] [Abstract][Full Text] [Related]
48. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality.
Roghi A; Savonitto S; Cavallini C; Arraiz G; Angoli L; Castriota F; Bernardi G; Sansa M; De Servi S; Pitscheider W; Danzi GB; Reimers B; Klugmann S; Zaninotto M; Ardissino D;
J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):375-81. PubMed ID: 18334892
[TBL] [Abstract][Full Text] [Related]
49. Grade 3 ischemia on the admission electrocardiogram predicts failure of ST resolution and of adequate flow restoration after primary percutaneous coronary intervention for acute myocardial infarction.
Wolak A; Yaroslavtsev S; Amit G; Birnbaum Y; Cafri C; Atar S; Gilutz H; Ilia R; Zahger D
Am Heart J; 2007 Mar; 153(3):410-7. PubMed ID: 17307421
[TBL] [Abstract][Full Text] [Related]
50. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
51. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
Januzzi JL; Newby LK; Murphy SA; Pieper K; Antman EM; Morrow DA; Sabatine MS; Ohman EM; Cannon CP; Braunwald E
Am Heart J; 2006 Feb; 151(2):360-6. PubMed ID: 16442899
[TBL] [Abstract][Full Text] [Related]
52. [Characteristics and mortality following primary percutaneous coronary intervention for acute myocardial infarction in Spain. Results from the TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry].
Cequier A; Bueno H; Augé JM; Bardají A; Fernández-Ortiz A; Heras M
Rev Esp Cardiol; 2005 Apr; 58(4):341-50. PubMed ID: 15847730
[TBL] [Abstract][Full Text] [Related]
53. Inverse relation between diastolic blood pressure and long-term outcomes in patients undergoing pharmacoinvasive therapy for myocardial infarction: the J-shaped relation in the contemporary era of revascularisation.
Lee CH; Foo D; Wong HB; Hong EC; Seow SC; Ng KS; Lim YT; Tan HC
J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):806-11. PubMed ID: 17060806
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.
Mehta RH; Ou FS; Peterson ED; Shaw RE; Hillegass WB; Rumsfeld JS; Roe MT;
JACC Cardiovasc Interv; 2009 Jan; 2(1):56-64. PubMed ID: 19463399
[TBL] [Abstract][Full Text] [Related]
55. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
[TBL] [Abstract][Full Text] [Related]
56. Time to treatment and ST-segment resolution in high-risk patients with acute myocardial infarction transferred from community hospitals for coronary angioplasty after pharmacological treatment.
Manari A; Tomasi C; Guiducci V; Zanoni P; Pignatelli G; Giacometti P
J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):32-8. PubMed ID: 18268416
[TBL] [Abstract][Full Text] [Related]
57. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
[TBL] [Abstract][Full Text] [Related]
58. Effects of direct stenting on epicardial and myocardial perfusion in patients with acute ST segment elevation myocardial infarction.
Gasior M; Gierlotka M; Pres D; Lekston A; Zebik T; Hawranek M; Tajstra M; Stasik-Pres G; Kalarus Z; Poloński L
Kardiol Pol; 2007 May; 65(5):503-12; discussion 513-4. PubMed ID: 17577847
[TBL] [Abstract][Full Text] [Related]
59. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
[TBL] [Abstract][Full Text] [Related]
60. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
